|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Sep 23, 2004 |
Title |
De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Background: Despite significant improvements in short-term kidney transplant survival, comparable increases in 5 and 10-year outcomes have not been achieved. Chronic allograft nephropathy (CAN) is a major cause of late graft loss. Toxic nephropathy and inadequate long-term immunosuppression are possible factors. We performed a randomized prospective trial comparing calcineurin inhibitor (CNI)-free to CNI-based immunosuppression to determine the impact on renal function, structure, and gene expression.
Methods: Sixty-one kidney recipients received mycophenolate mofetil (MMF), and prednisone (P). Randomized patients received concentration-controlled sirolimus or cyclosporine. Two years post-transplant 55 patients underwent renal function studies, 48 (87%) underwent transplant biopsies; all classified by Banff scoring and 41 by DNA microarrays.
Findings: Comparing sirolimus/MMF/P to cyclosporine/MMF/P at two years, there was a significantly lower serum creatinine (1.35 vs. 1.81 mg/dl; p=0.008), significantly higher Cockroft-Gault glomerular filtration rate (GFR) (80.4 vs. 63.4 cc/min; p=0.008), iothalamate GFR (60.6 vs. 49.2 cc/min; p= 0.018), and Banff 0 (normal) biopsies (66.6 vs. 20.8%; p=0.013). Regression analysis of calculated GFR’s from 1 to 36 months yielded a positive slope for sirolimus of 3.36 ml/min/year, and a negative slope for cyclosporine of –1.58 ml/min/year (p=0.008). Gene expression profiles of kidney biopsies with higher Banff CAN scores confirmed significant up regulation of genes responsible for immune/inflammation and fibrosis/tissue remodeling.
Interpretation: At two years the sirolimus-treated patients have better renal transplant function, a diminished prevalence of CAN, and down regulated expression of genes responsible for the progression of CAN. All may provide for an alternative natural history with improved graft survival. Keywords = Cyclosporine Keywords = Sirolimus Keywords = Transplantation Keywords = DNA microarrays Keywords = calcineurin inhibitors Keywords: parallel sample
|
|
|
|
|
Contributor(s) |
Flechner SM, Kurian SM, Solez K, Cook DJ, Rollin H, Burke JT, Hammond JA, Whisenant TC, Lanigan CM, Head SR, Salomon DR |
Citation(s) |
15476476 |
Submission date |
Sep 09, 2004 |
Last update date |
Aug 10, 2018 |
Contact name |
Sunil Kurian |
E-mail(s) |
smkurian@scripps.edu
|
Phone |
858-784-7759
|
Organization name |
The Scripps Research Institute
|
Department |
Molecular and Experimental Medicine
|
Street address |
10550 N Torrey Pines Road
|
City |
La Jolla |
State/province |
CA |
ZIP/Postal code |
92037 |
Country |
USA |
|
|
Platforms (1) |
GPL96 |
[HG-U133A] Affymetrix Human Genome U133A Array |
|
Samples (41)
|
|
Relations |
BioProject |
PRJNA90605 |
Supplementary data files not provided |
|
|
|
|
|